Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Banito

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Nature Cell Biology|April 28, 2026
Author Correction: A complex secretory program orchestrated by the inflammasome controls paracrine senescenceJuan Carlos Acosta, Ana Banito, Torsten Wuestefeld, et al.
Cancers|February 15, 2022
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft ModelsCharlotte Gatzweiler, Johannes Ridinger, Sonja Herter, et al.
Nature Cell Biology|October 1, 2015
Erratum: mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotypeNicolás Herranz, Suchira Gallage, Massimiliano Mellone, et al.
Nature Communications|July 15, 2025
Subversion of mRNA degradation pathways by EWSR1::FLI1 represents a therapeutic vulnerability in Ewing sarcomaBartimée Galvan, Loïc Ongena, Jonathan Bruyr, et al.
Nature Communications|January 3, 2024
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusionsJulia Schöpf, Sebastian Uhrig, Christoph E Heilig, et al.
Molecular Cancer|January 4, 2022
Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcomaFlorencia Cidre-Aranaz, Jing Li, Tilman L B Hölting, et al.
Nature Communications|June 16, 2025
Somatic gene delivery faithfully recapitulates a molecular spectrum of high-risk sarcomasRoland Imle, Daniel Blösel, Felix K F Kommoss, et al.
Cancer Communications (London, England)|March 15, 2025
Comprehensive DSRCT multi-omics analyses unveil CACNA2D2 as a diagnostic hallmark and super-enhancer-driven EWSR1::WT1 signature geneFlorian Henning Geyer, Alina Ritter, Seneca Kinn-Gurzo, et al.
The Journal of Clinical Investigation|October 16, 2025
High 4E-BP1 expression associates with chromosome 8 gain and CDK4/6 sensitivity in Ewing sarcomaCornelius M Funk, Anna C Ehlers, Martin F Orth, et al.
EMBO Molecular Medicine|October 13, 2020
Sarcoma treatment in the era of molecular medicineThomas Gp Grünewald, Marta Alonso, Sofia Avnet, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Nature Cell Biology|April 28, 2026
Author Correction: A complex secretory program orchestrated by the inflammasome controls paracrine senescenceJuan Carlos Acosta, Ana Banito, Torsten Wuestefeld, et al.
Cancers|February 15, 2022
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft ModelsCharlotte Gatzweiler, Johannes Ridinger, Sonja Herter, et al.
Nature Cell Biology|October 1, 2015
Erratum: mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotypeNicolás Herranz, Suchira Gallage, Massimiliano Mellone, et al.
Nature Communications|July 15, 2025
Subversion of mRNA degradation pathways by EWSR1::FLI1 represents a therapeutic vulnerability in Ewing sarcomaBartimée Galvan, Loïc Ongena, Jonathan Bruyr, et al.
Nature Communications|January 3, 2024
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusionsJulia Schöpf, Sebastian Uhrig, Christoph E Heilig, et al.
Molecular Cancer|January 4, 2022
Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcomaFlorencia Cidre-Aranaz, Jing Li, Tilman L B Hölting, et al.
Nature Communications|June 16, 2025
Somatic gene delivery faithfully recapitulates a molecular spectrum of high-risk sarcomasRoland Imle, Daniel Blösel, Felix K F Kommoss, et al.
Cancer Communications (London, England)|March 15, 2025
Comprehensive DSRCT multi-omics analyses unveil CACNA2D2 as a diagnostic hallmark and super-enhancer-driven EWSR1::WT1 signature geneFlorian Henning Geyer, Alina Ritter, Seneca Kinn-Gurzo, et al.
The Journal of Clinical Investigation|October 16, 2025
High 4E-BP1 expression associates with chromosome 8 gain and CDK4/6 sensitivity in Ewing sarcomaCornelius M Funk, Anna C Ehlers, Martin F Orth, et al.
EMBO Molecular Medicine|October 13, 2020
Sarcoma treatment in the era of molecular medicineThomas Gp Grünewald, Marta Alonso, Sofia Avnet, et al.
Pageof 6